Results 91 to 100 of about 6,710,280 (212)

Immunology Highlights of Four Major Idiosyncratic DILI Subtypes Verified by the RUCAM: A New Evidence-Based Classification

open access: yesLivers
Conventionally, drug-induced liver injury (DILI) exists in two types: idiosyncratic and intrinsic. Both types are classified as non-immune disorders, thereby ignoring that some iDILI cases may have an immune or autoimmune background that requires a ...
Rolf Teschke
doaj   +1 more source

Liver Organoids: From Disease Modelling to Regenerative Medicine

open access: yesCell Proliferation, EarlyView.
Liver organoids provide a versatile platform for disease modelling and drug discovery, leveraging stem cells and engineering techniques. They bridge research and clinical applications, offering significant potential for advancing precision medicine and regenerative therapies for liver diseases.
Tiepeng Wang   +5 more
wiley   +1 more source

Pathophysiological Differences and Differential Diagnosis of Autoimmune and Drug-Induced Hepatitis

open access: yesLivers
Autoimmune hepatitis (AIH) and drug-induced liver injury (DILI) are major causes of liver inflammation with distinct pathophysiology but overlapping clinical features.
Nicola Zeni   +4 more
doaj   +1 more source

Rare Variants in PFIC‐Related Genes Among Adults With Intrahepatic Cholestasis

open access: yesHepatology Research, EarlyView.
ABSTRACT Aim Biallelic pathogenic variants in progressive familial intrahepatic cholestasis (PFIC)‐related genes cause severe pediatric cholestasis. However, the clinical significance of heterozygous variants in adult intrahepatic cholestasis remains unclear.
Shunji Hirose   +9 more
wiley   +1 more source

Matrix factorization-based data fusion for drug-induced liver injury prediction [PDF]

open access: yes
We report on a data fusion approach for prediction of outcome of drug-induced liver injury (DILI) in humans from gene expression studies as provided by the CAMDA 2013 Challenge.
Zupan, Blaz, Zitnik, Marinka
core   +2 more sources

Drug-induced liver injuries (Part 1)

open access: yesРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии, 2012
The aim of review. To present modern concepts on mechanisms of drug-induced liver injury (DILI), to give their classification, to present approaches to disease diagnostics.Original positions.
S. F. Galimova
doaj  

Development of Prediction Models for Drug-Induced Cholestasis, Cirrhosis, Hepatitis, and Steatosis Based on Drug and Drug Metabolite Structures

open access: yesFrontiers in Pharmacology, 2020
Drug-induced liver injury (DILI) is one of the major reasons for termination of drug development. Due to the importance of predicting DILI in early phases of drug development, diverse in silico models have been developed to filter out DILI-causing ...
Hyun Kil Shin   +7 more
doaj   +1 more source

Cyclin‐dependent kinase 4/6 (CDK4/6) inhibitor‐induced hepatotoxicity and its resolution: a study of seven cases

open access: yesHistopathology, EarlyView.
CDK4/6 inhibitor‐induced liver injury represents a clinically significant and histologically distinctive form of drug‐induced hepatotoxicity, most commonly encountered with ribociclib. The predominant pattern is severe acute hepatocellular injury, frequently accompanied by lymphocytic cholangitis, a combination that, in the appropriate clinical context,
Sunayana Misra   +4 more
wiley   +1 more source

Lipidic obstruction of sinusoids (LOS): a potentially serious complication of steatotic liver disease

open access: yesHistopathology, EarlyView.
Lipidic obstruction of sinusoids is a particular histological pattern that can occur in fatty livers following liver damage and is characterized by extracellular fat deposition impairing sinusoidal blood flow. Introduction During routine examination of specimens from patients with steatotic liver disease (SLD), we repeatedly observed a peculiar ...
Katharina Endhardt   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy